1 |
Collet AR, Story DF. Is catecholamine release from the rabbit adrenal gland subject to regulation through dopamine receptors or beta-adrenoceptors? Clin Exp Pharmacol Physiol 9: 436, 1982a
|
2 |
Collet AR, Story DF. Release of -adrenaline from an isolated intact preparation of the rabbit adrenal gland: no evidence for release modulatory alpha-adrenoceptors. J Auton Pharmacol 2: 25-34, 1982b
DOI
PUBMED
|
3 |
Dahmer MK, Senogles SE. Atypical SCH23390 binding sites are present on bovine adrenal medullary membranes. Neurochem Res 25: 321-326, 2000
DOI
ScienceOn
|
4 |
Dahmer MK, Senogles SE. Differential inhibition of secretagogue-stimulated sodium uptake in adrenal chromaffin cells by activation of and dopamine receptors. J Neurochem 67: 1960-1964, 1996
DOI
PUBMED
ScienceOn
|
5 |
Dahmer MK, Senogles SE. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by and receptors. J Neurochem 66: 222-232, 1996
DOI
PUBMED
ScienceOn
|
6 |
Damase-Michel C, Montastruc JL, Tran MA. Dopaminergic inhibition of catecholamine secretion from adrenal medulla is mediated by $D_2$-like but not -like dopamine receptors. Clin Expt Pharmacol Physiol 26(suppl): S67-S68, 1999
|
7 |
Gonzales MC, Artalejo AR, Montiel C, Hervas PP, Garcia AG. Characterization of a dopaminergic receptor that modulates adrenomedullary catecholamine release. J Neurochem 47: 382-388, 1986
DOI
PUBMED
|
8 |
Kujacic M, Carlsson A. In vivo activity of tyrosine hydroxylase in rat adrenal glands following administration of quinpirole and dopamine. Eur J Pharmacol 278: 9-15, 1995
DOI
ScienceOn
|
9 |
Lyon RA, Titeler M, Bigornia L, Schneider AS. dopamine receptors on bovine chromaffin cell membranes: identification and characterization by N-methylspiperone binding. J Neurochem 48: 631-635, 1987
DOI
PUBMED
|
10 |
Quick M, Bergeron L, Mount H, Philte J. Dopamine receptor binding in adrenal medulla: charadcterization using spiperone. Biochem Pharmacol 36: 3707-3713, 1987
DOI
ScienceOn
|
11 |
Schoors DF, Vauquelin GP, De Vos H, Smets G, Velkeniers B, Vanhaelst L, Dupont AG. Identification of a dopamine receptor, not linked to adenylate cyclase, on lactotroph cells. Br J Pharmacol 103: 1928-1934, 1991
DOI
PUBMED
ScienceOn
|
12 |
Damase-Michel C, Montastruc JL, Geelen G, Saint-Blanquat GD, Tran MA. Effect of quinpirole a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs. J Pharmacol Expt Ther 252: 770-777, 1990
|
13 |
Wakade AR. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J Physiol 313: 463-480, 1981
DOI
PUBMED
|
14 |
Damase-Michel C, Montastruc JL, Tran MA. Effects of dopaminergic drugs on the sympathoadrenal system. Hypertens Res 18(Suppl 1): S119-24, 1995
DOI
ScienceOn
|
15 |
Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of channels. Nature 303: 535-537, 1982
DOI
ScienceOn
|
16 |
Starke K. Presynaptic autoreceptors in the third decade: focus on alpha2-adrenoceptors. J Neurochem 78: 685-693, 2001
DOI
PUBMED
ScienceOn
|
17 |
Tallarida RJ, Murray RB. Manual of pharmacologic calculation with computer programs. 2nd ed. Speringer-Verlag, New York, p 132, 1987
|
18 |
Mercuro G, Gessa G, Rivano CA, Lai L, Cherchi A. Evidence for a dopaminergic control of sympathoadrenal catecholamine release. Am J Cardiol 62(10 Pt 1): 827-828, 1988
DOI
ScienceOn
|
19 |
Bigornia L, Suozzo M, Ryan KA, Napp D, Schneider AS. Dopamine receptors on adrenal chromaffin cells modulate calcium uptake and catecholamine release. J Neurochem 51: 999-1006, 1988
DOI
PUBMED
|
20 |
Mannelli M, Pupilli C, Fabbri G, Musante R, De Feo ML, Franchi F, Guisti G. Endogenous dopamine (DA) and DA2 receptors: a mechanism limiting excessive sympatheticadrenal discharge in humans. J Clin Endocrinol Metab 66: 626-631, 1988
DOI
PUBMED
|
21 |
Mannelli M, Lanzillotti R, Ianni L, Pupilli C, Serio M. Dopaminergic modulation of human adrenal medulla: indirect evidence for the involvement of DA-2 receptors located on chromaffin cells. J Auton Pharmacol 10 Suppl 1: 79-84, 1990
|
22 |
Foucart S, Lacaille-Belanger P, Kimura T, Nadeau R, De Champlain J. Modulation of adrenal catecholamine release by dopamine receptors in the anaesthetized dog. Clin Exp Pharmacol Physiol 15: 601-611, 1988
DOI
PUBMED
|
23 |
Chu E, Chu TC, Potter DE. Potential sites of action of TNPA: a dopamine-2 receptor agonist. Exp Eye Res 69: 611-616, 1999
DOI
ScienceOn
|
24 |
Suzuki M, Muraki K, Imaizumi Y, Watanabe M. Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum -pump, reduces -dependent currents in guinea-pig smooth muscle cells. Br J Pharmacol 107: 134-140, 1992
DOI
PUBMED
ScienceOn
|
25 |
Hammer R, Giachetti A. Muscarinic receptor subtypes: and biochemical and functional characterization. Life Sci 31: 2992-2998, 1982
|
26 |
Lim DY, Kim KH, Choi CH, Yoo HJ, Choi DJ, Lee EH. Studies on secretion of catecholamines evoked by metolclopramide of the rat adrenal gland. Korean J Pharmacol 25: 31-42, 1989
|
27 |
Montastruc JL, Gaillard G, Rascol O, Tran MA, Montastruc P. Effect of apomorphine on adrenal medullary catecholamine levels. Fundam Clin Pharmacol 3: 665-670, 1989
DOI
ScienceOn
|
28 |
Villanueva M, Wightman RM. Facilitation of quantal release induced by a -like receptor on bovine chromaffin cells. Biochem 46: 3881-3887, 2007
DOI
ScienceOn
|
29 |
Andersen PH, Jansen JA. Dopamine receptor agonists: selectivity and receptor efficacy. Eur J Pharmacol 188: 335-347, 1990
DOI
ScienceOn
|
30 |
Takemura H, Hughes AR, Thastrup O, Putney JW Jr. Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane. J Biol Chem 264: 12266-12271, 1989
PUBMED
|
31 |
Montiel C, Artalejo AR, Bermejo PM, Sanchez-Garcia P. A dopaminergic receptor in adrenal medulla as a possible site of action for the droperidol-evoked hypertensive response. Anesthesiology 65: 474-479, 1986
DOI
PUBMED
|
32 |
Cheek TR, O'Sullivan AJ, Moreton RB, Berridge MJ, Burgoyne RD. Spatial localization of the stimulus-induced rise in cyrosolic in bovine adrenal chromaffin cells: distinct nicotinic and muscarinic patterns. FEBS Lett 247: 429-434, 1989
DOI
ScienceOn
|
33 |
Fasolato C, Innocenti B, Pozzan T. Receptor-activated influx: how many mechanisms for how many channels? Trends Pharmacol Sci 15:77-83, 1994
DOI
ScienceOn
|
34 |
Gessa L, Canu A, Del Zompo M, Burrai C, Serra G. Lack of acute antipsychotic effect of SCH23390, a selective dopamine receptor antagonist. Lancet 337: 854-855, 1991
PUBMED
|
35 |
Nagahama S, Chen YF, Lindheimer MD, Oparil S. Mechanism of the pressor action of LY171555, a specific dopamine receptor agonist, in the conscious rat. J Pharmacol Exp Ther 236: 735-742, 1986
PUBMED
|
36 |
Wada A, Takara H, Izumi F, Kobayashi H, Yanagihara N. Influx of through acetylcholine receptor-associated Na channels: relationship between influx, influx and secretion of catecholamines in cultured bovine adrenal medulla cells. Neuroscience 15: 283-292, 1985
DOI
ScienceOn
|
37 |
Lim DY, Hwang DH. Studies on secretion of catecholamines evoked by DMPP and McN-A-343 in the rat adrenal gland. Korean J Pharmacol 27: 53-67, 1991
|
38 |
Kujacic M, Svensson K, Lofberg L, Carlsson A. Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors. J Neural Transm Gen Sect 84: 195-209, 1991
DOI
ScienceOn
|
39 |
Akaike A, Mine Y, Sasa M, Takaori S. Voltage and current clamp studies of muscarinic and nicotinic excitation of the rat adrenal chromaffin cells. J Pharmacol Expt Ther 255: 333-339, 1990
|
40 |
Kujacic M, Svensson K, Lofberg L, Carlsson A. Acute changes in dopamine levels in rat adrenal gland after administration of dopamine receptor agonists and antagonists. Eur J Pharmacol 177: 163-170, 1990
DOI
ScienceOn
|
41 |
Kujacic M, Carlsson A. Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors. J Neural Transm Gen Sect 92: 73-79, 1993
DOI
ScienceOn
|
42 |
Artalejo CR, Ariano MA, Perlman RL, Fox AP. Activation of facilitation calcium channels in chromaffin cells by dopamine receptors through a AMP/protein Kinase A-dependent mechanism. Nature 348: 239-242, 1990
DOI
ScienceOn
|
43 |
Benoit-Marand M, Borrelli E, Gonon F. Inhibition of dopamine release via presynaptic receptors: time course and functional characteristics in vivo. J Neurosci 21: 9134-9141, 2001
DOI
PUBMED
|
44 |
Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L. Ihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 309: 69-71, 1984
DOI
ScienceOn
|
45 |
Artalejo CR, Dahmer MK, Perlman RL, Fox AP. Two types of currents are found in bovine chromaffin cells: facilitation is due to the recruitment of one type. J Physiol 432: 681-707, 1991
DOI
PUBMED
|
46 |
O'Boyle KM, Gaitanopoulos DE, Brenner M, Waddington JL. Agonist and antagonist properties of benzazepine and thienopyrine derivates at the dopamine receptor. Neuropharmacol 28: 401-405, 1989
DOI
ScienceOn
|
47 |
Regunathan S, Missala K, Sourkes TL. Central regulation of adrenal tyrosine hydroxylase: effect of induction on catecholamine levels in the adrenal medulla and plasma. J Neurochem 53: 1706-1710, 1989
DOI
PUBMED
|
48 |
Berridge MJ. Inositol trisphosphate and calcium signaling. Ann NY Acad Sci 766: 31-43, 1995
DOI
|
49 |
Albillos A, Abad F, Garcia AG. Cross-talk between muscarinic and dopamine receptors in the cat adrenal medulla. Biochem Biophys Res Commun 183: 1019-1024, 1992
DOI
ScienceOn
|
50 |
Anton AH, Sayre DF. A study of the factors affecting the aluminum oxidetrihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360-375, 1962
PUBMED
|
51 |
Challiss RAJ, Jones JA, Owen PJ, Boarder MR. Changes in inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass accumulations in cultured adrenal chromaffin cells in response to bradykinin and histamine. J Neurochem 56: 1083-1086, 1991
DOI
PUBMED
|
52 |
Artalejo CR, Garcia AG, Montiel C, Sanchez-Garcia P. A dopaminergic receptor modulates catecholamine release from the cat adrenal gland. J Physiol 362: 359-368, 1985
DOI
PUBMED
|
53 |
Lim DY, Yoon JK, Moon B. Interrelationship between dopaminergic receptors and catecholamine secretion from the rat adrenal gland. Korean J Pharmacol 30: 87-100, 1994
|
54 |
Seidler NW, Jona I, Vegh N, Martonosi A. Cyclopiazonic acid is a specific inhibitor of the -ATPase of sarcoplasimc reticulum. J Biol Chem 264: 17816-17823, 1989
PUBMED
|
55 |
Huettl P, Gerhardt GA, Browning MD, Masserano JM. Effects of dopamine receptor agonists and antagonists on catecholamine release in bovine chromaffin cells. J Pharmacol Expt Ther 257: 567-574, 1991
|
56 |
Lewis MM, Watts VJ, Lawler P, Nichols E, Mailman RB. Homologous desensitization of the dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency. J Pharmacol Exp Ther 286: 345-353, 1998
PUBMED
|
57 |
Bigornia L, Allen CN, Jan CR, Lyon RA, Titeler M, Schneider AS. dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells. J Pharmacol Expt Ther 252: 586-592, 1990
|
58 |
Lim DY, Kim CD, Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res 15: 115-125, 1992
DOI
ScienceOn
|
59 |
Goeger DE, Riley RT. Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on binding and permeability. Biochem Pharmacol 38: 3995-4003, 1989
DOI
ScienceOn
|